Premium
Novavax Inc (NVV1)
TG
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-20 | Mr. Richard J. RodgersIndependent Director | 18,88k | 0,00 | Derivative Exercise and Retained Stock | - | 47,37k | 66,27% |
| 2026-06-20 | Ms. Rachel K. KingIndependent Director | 18,88k | 0,00 | Derivative Exercise and Retained Stock | - | 44,07k | 74,95% |
| 2026-06-20 | Dr. Richard Huntington DouglasIndependent Director | 18,88k | 0,00 | Derivative Exercise and Retained Stock | - | 73,22k | 34,74% |
| 2026-06-20 | Ms. Margaret G. McGlynnIndependent Vice Chair of the Board of Directors | 18,88k | 0,00 | Derivative Exercise and Retained Stock | - | 44,47k | 73,78% |
| 2026-06-20 | Mr. David M. MottChairman of the Board of Directors | 18,88k | 0,00 | Derivative Exercise and Retained Stock | - | 79,77k | 31,01% |
| 2026-06-20 | Mr. Gregg Huber AltonIndependent Director | 18,88k | 0,00 | Derivative Exercise and Retained Stock | - | 47,69k | 65,54% |
| 2026-04-25 | Mr. Charles W. NewtonIndependent Director | 9,52k | 0,00 | Derivative Exercise and Retained Stock | - | 9,52k | - |
| 2026-03-10 | Dr. John W. ShiverIndependent Director | 7,95k | 0,00 | Derivative Exercise and Retained Stock | - | 7,95k | - |
| 2026-03-07 | Mr. James Patrick KellyExec. VP, CFO & Treasurer | 6,32k | 0,00 | Derivative Exercise and Retained Stock | - | 130,60k | 5,08% |
| 2026-03-07 | Mr. James Patrick KellyExec. VP, CFO & Treasurer | -5,90k | 58,92k | Derivative Exercise and Sale | 9,98 | 130,60k | - |
| 2026-03-03 | Mr. James Patrick KellyExec. VP, CFO & Treasurer | 22,32k | 0,00 | Derivative Exercise and Retained Stock | - | 124,28k | 21,89% |
| 2026-03-03 | Mr. James Patrick KellyExec. VP, CFO & Treasurer | -20,85k | 197,87k | Derivative Exercise and Sale | 9,49 | 124,28k | - |
| 2026-03-03 | Mr. John Charles JacobsPresident, CEO & Director | 80,88k | 0,00 | Derivative Exercise and Retained Stock | - | 225,68k | 55,86% |
| 2026-03-03 | Mr. John Charles JacobsPresident, CEO & Director | -69,29k | 657,54k | Derivative Exercise and Sale | 9,49 | 225,68k | - |
| 2026-03-03 | Ms. Elaine O'HaraExec. VP & Chief Strategy Officer | 33,91k | 0,00 | Derivative Exercise and Retained Stock | - | 134,64k | 33,66% |
| 2026-03-03 | Ms. Elaine O'HaraExec. VP & Chief Strategy Officer | -22,43k | 212,85k | Derivative Exercise and Sale | 9,49 | 134,64k | - |
| 2026-03-03 | Mr. Mark J. CaseyExec. VP, Chief Legal Officer & Corporate Secretary | 26,12k | 0,00 | Derivative Exercise and Retained Stock | - | 90,07k | 40,85% |
| 2026-03-03 | Mr. Mark J. CaseyExec. VP, Chief Legal Officer & Corporate Secretary | -11,38k | 107,98k | Derivative Exercise and Sale | 9,49 | 90,07k | - |
| 2026-03-03 | Dr. Ruxandra Draghia-AkliInitié | 15,35k | 0,00 | Derivative Exercise and Retained Stock | - | 23,56k | 187,04% |
| 2026-03-03 | Dr. Ruxandra Draghia-AkliInitié | -11,31k | 107,36k | Derivative Exercise and Sale | 9,49 | 23,56k | - |
| 2026-03-01 | Mr. John Charles JacobsPresident, CEO & Director | 44,88k | 0,00 | Derivative Exercise and Retained Stock | - | 225,68k | 24,83% |
| 2026-03-01 | Mr. John Charles JacobsPresident, CEO & Director | -38,45k | 389,88k | Derivative Exercise and Sale | 10,14 | 225,68k | - |
| 2026-03-01 | Mr. James Patrick KellyExec. VP, CFO & Treasurer | 30,30k | 0,00 | Derivative Exercise and Retained Stock | - | 101,96k | 42,28% |
| 2026-03-01 | Mr. James Patrick KellyExec. VP, CFO & Treasurer | -28,37k | 287,63k | Derivative Exercise and Sale | 10,14 | 101,96k | - |
| 2026-03-01 | Ms. Elaine O'HaraExec. VP & Chief Strategy Officer | 43,26k | 0,00 | Derivative Exercise and Retained Stock | - | 100,74k | 75,25% |
| 2026-03-01 | Ms. Elaine O'HaraExec. VP & Chief Strategy Officer | -16,34k | 165,73k | Derivative Exercise and Sale | 10,14 | 100,74k | - |
| 2026-03-01 | Mr. Mark J. CaseyExec. VP, Chief Legal Officer & Corporate Secretary | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 63,95k | 4,56% |
| 2026-03-01 | Mr. Mark J. CaseyExec. VP, Chief Legal Officer & Corporate Secretary | -1,21k | 12,31k | Derivative Exercise and Sale | 10,14 | 63,95k | - |
| 2026-01-23 | Mr. John Charles JacobsPresident, CEO & Director | 44,07k | 0,00 | Derivative Exercise and Retained Stock | - | 180,80k | 32,23% |
| 2026-01-23 | Mr. John Charles JacobsPresident, CEO & Director | -39,13k | 358,84k | Derivative Exercise and Sale | 9,17 | 180,80k | - |
| 2025-12-11 | Mr. Mark J. CaseyExec. VP, Chief Legal Officer & Corporate Secretary | 29,19k | 0,00 | Derivative Exercise and Retained Stock | - | 61,16k | 91,28% |
| 2025-12-11 | Mr. Mark J. CaseyExec. VP, Chief Legal Officer & Corporate Secretary | -12,71k | 85,05k | Derivative Exercise and Sale | 6,69 | 61,16k | - |
| 2025-11-11 | Dr. Ruxandra Draghia-AkliInitié | 8,21k | 0,00 | Derivative Exercise and Retained Stock | - | 8,21k | - |
| 2025-11-11 | Dr. Ruxandra Draghia-AkliInitié | -6,05k | 44,76k | Derivative Exercise and Sale | 7,40 | 8,21k | - |
| 2025-10-16 | Shah Capital Management, IncSociété | 1,65M | 12,94M | Achat | 7,16 - 8,59 | 12,65M | 15,00% |
| 2025-10-29 | Mr. Richard J. RodgersIndependent Director | 3,80k | 0,00 | Derivative Exercise and Retained Stock | - | 28,49k | 15,39% |
| 2025-08-21 | Shah Capital Management, IncSociété | 356,00k | 2,70M | Achat | 7,48 - 7,63 | 11,00M | 3,34% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
